SABCS: Anastrozole Tied to Lasting Reduction in Breast Cancer Risk
Breast cancer risk significantly lower at median follow-up of 131 months; effect continued after treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.